Palazestrant
Product Specifications
CAS Number
2092925-89-6
Synonyms
OP-1250
SKU
C01903-5mg
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Additionnal Information
Palazestrant (OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
504-05a 1 Cryovial
Cryopreserved Tracheal Epithelial Cells (HTEpC), adult
Sign In for Pricing
View Details 